Termination of proposed combination with HOOKIPA Pharma Inc.

Further to the 2.4 announcement on 2 January 2025 on the potential combination of Poolbeg Pharma ("Poolbeg" or the "Company") and HOOKIPA Pharma Inc ("HOOKIPA"), the Board of Poolbeg announces that it was informed yesterday that HOOKIPA has terminated discussions on the proposed combination of the two companies.

Cathal Friel, Executive Chairman of Poolbeg, said: "We were surprised and disappointed to hear of HOOKIPA's decision to withdraw from the combination discussions. Throughout this process, we have seen strong interest in the potential of POLB 001 and we continue to be focused on maximising the potential of our in-house programmes and exploring new opportunities to generate value for our shareholders."